The Korean Journal of Medicine

  • 제84권2호
  • /
  • Pages.269-273
  • /
  • 2013
  • /
  • 1738-9364(pISSN)
  • /
  • 2289-0769(eISSN)
대한내과학회 (The Korean Association of Internal Medicine)
권호 표지
DOI QR코드

DOI QR Code

항응고요법 중 재발한 신경색증을 동반한 원발성 항인지질증후군 1예

A Case of Primary Anti-Phospholipid Syndrome with Recurrent Renal Infarction

  • 김민희 (인제대학교 의과대학 상계백병원 내과) ;
  • 고충원 (인제대학교 의과대학 상계백병원 내과) ;
  • 김상현 (인제대학교 의과대학 상계백병원 내과) ;
  • 한성훈 (인제대학교 의과대학 상계백병원 내과) ;
  • 장기준 (인제대학교 의과대학 상계백병원 내과) ;
  • 황진태 (인제대학교 의과대학 상계백병원 내과) ;
  • 유성인 (인제대학교 의과대학 상계백병원 내과)
  • Kim, Min Hee (Department of Internal Medicine, Sanggye Paik Hospital, Inje University College of Medicine) ;
  • Goh, Choong-Won (Department of Internal Medicine, Sanggye Paik Hospital, Inje University College of Medicine) ;
  • Kim, Sang Hyun (Department of Internal Medicine, Sanggye Paik Hospital, Inje University College of Medicine) ;
  • Han, Seong Hoon (Department of Internal Medicine, Sanggye Paik Hospital, Inje University College of Medicine) ;
  • Chang, Ki Jun (Department of Internal Medicine, Sanggye Paik Hospital, Inje University College of Medicine) ;
  • Hwang, Jin Tae (Department of Internal Medicine, Sanggye Paik Hospital, Inje University College of Medicine) ;
  • Yu, Sung In (Department of Internal Medicine, Sanggye Paik Hospital, Inje University College of Medicine)
  • 투고 : 2012.03.20
  • 심사 : 2012.06.08
  • 발행 : 2013.02.01
⟨ 이전 논문 다음 논문 ⟩

초록

원발성 항인지질증후군은 주로 정맥 혈전증으로 나타나게 되며 동맥 혈전증과 관련된 사례는 드물다. 저자들은 국내에 보고된 바 없는 항응고요법 중 재발한 신경색증으로 진단된 원발성 항인지질증후군을 경험하였다. 이에 문헌고찰과 함께 보고하는 바이다.

Anti-phospholipid syndrome is characterized by the occurrence of venous or arterial thrombosis in the presence of anti-phospholipid antibodies and is associated with morbidity during pregnancy. Arterial thromboses are less common than venous thromboses and most frequently manifest with features consistent with ischemia or infarction. Only a few cases of arterial thrombosis with primary anti-phospholipid syndrome have been reported in Korea. We report a 41-year-old man with anti-phospholipid syndrome who had abdominal pain due to a recurrent renal infarction, and we review the literature on anti-phospholipid syndrome.

키워드

참고문헌

  1. Lim W, Crowther MA, Eikelboom JW. Management of antiphospholipid antibody syndrome: a systematic review. JAMA 2006;295:1050-1057. https://doi.org/10.1001/jama.295.9.1050
  2. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002;346:752-763. https://doi.org/10.1056/NEJMra002974
  3. Ruiz-Irastorza G, Khamashta MA, Hunt BJ, Escudero A, Cuadrado MJ, Hughes GR. Bleeding and recurrent thrombosis in definite antiphospholipid syndrome: analysis of a series of 66 patients treated with oral anticoagulation to a target international normalized ratio of 3.5. Arch Intern Med 2002;162:1164-1169. https://doi.org/10.1001/archinte.162.10.1164
  4. Paris B, Bobrie G, Rossignol P, Le Coz S, Chedid A, Plouin PF. Blood pressure and renal outcomes in patients with kidney infarction and hypertension. J Hypertens 2006;24: 1649-1654. https://doi.org/10.1097/01.hjh.0000239302.55754.1f
  5. Krishnan P, Anandh U, Fernandes DK, Somiah S, Vincent L. Renal failure in a patient with primary antiphospholipid syndrome. J Assoc Physicians India 2002;50:964-966.
  6. Amigo MC, Garcia-Torres R, Robles M, Bochicchio T, Reyes PA. Renal involvement in primary antiphospholipid syndrome. J Rheumatol 1992;19:1181-1185.
  7. Kincaid-Smith P, Fairley KF, Kloss M. Lupus anticoagulant associated with renal thrombotic microangiopathy and pregnancy-related renal failure. Q J Med 1988;68:795-815.
  8. D'Agati V, Kunis C, Williams G, Appel GB. Anti-cardiolipin antibody and renal disease: a report three cases. J Am Soc Nephrol 1990;1:777-784.
  9. Rosove MH, Brewer PM. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann Intern Med 1992;117:303-308. https://doi.org/10.7326/0003-4819-117-4-303
  10. Finazzi G, Marchioli R, Brancaccio V, et al. A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS). J Thromb Haemost 2005;3:848-853. https://doi.org/10.1111/j.1538-7836.2005.01340.x